ENVERIC BIOSCIENCES, INC. Current Liabilities
ENVERIC BIOSCIENCES, INC. (ENVB) had Current Liabilities of $861.48 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $861.48K.
- 2026-03-31: Liabilities, Current $460.68K.
- 2025-12-31: Liabilities, Current $918.40K.
- 2025-09-30: Liabilities, Current $905.88K.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $861.48K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $460.68K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $918.40K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $905.88K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.36M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.18M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $1.49M 10-K · filed 2026-03-27 | |
| 2024-09-30 | $839.17K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $645.34K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $2.37M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $2.34M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $4.18M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $4.93M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $4.44M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $4.00M 10-K · filed 2024-03-26 | |
| 2022-09-30 | $2.60M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $2.32M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $2.09M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $2.74M 10-K/A · filed 2023-06-09 | $2.08M 10-K · filed 2022-03-31 |
| 2021-09-30 | $2.16M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.17M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $626.95K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $681.25K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $13.99M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $12.77M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $16.91M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $13.50M 10-Q · filed 2020-11-16 | $14.38M 10-K · filed 2020-03-25 |
| 2019-09-30 | $14.48M 10-K/A · filed 2020-08-12 | $13.41M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $13.52M 10-K/A · filed 2020-08-12 | $14.37M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $14.71M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $14.69M 10-K/A · filed 2020-08-12 | |
| 2018-09-30 | $12.86M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $25.06M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $26.47M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $30.37M 10-K · filed 2019-03-26 | |
| 2017-09-30 | $31.49M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $15.59M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $17.27M 10-Q/A · filed 2017-05-15 | |
| 2016-12-31 | $12.71M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $13.61M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $7.23M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $7.93M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $8.58M 10-K/A · filed 2017-04-04 | |
| 2015-09-30 | $14.85M 10-Q · filed 2015-11-23 | |
| 2015-06-30 | $9.32M 10-Q · filed 2015-08-18 | |
| 2015-03-31 | $3.49M 10-KT · filed 2016-03-15 | $10.34K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $8.96K 10-Q · filed 2015-05-14 | |
| 2014-09-30 | $2.30K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $2.00K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $3.02M 10-KT · filed 2016-03-15 | $4.78K 10-Q/A · filed 2014-05-08 |
| 2013-12-31 | $24.70K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $38.12K 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $35.30K 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $30.14K 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $25.67K 10-K · filed 2014-03-28 | |
| 2012-09-30 | $14.81K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $9.99K 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $9.79K 10-Q/A · filed 2012-05-10 | |
| 2011-12-31 | $17.89K 10-K · filed 2013-02-28 | |
| 2011-09-30 | $7.70K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $72.30K 10-Q · filed 2011-08-02 | |
| 2010-12-31 | $50.64K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |